| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
ETS proto-oncogene 1, transcription factor | 0.444 | 0.731 | 0.78 |
|
disease | 0.700 | None | 0.957 | 1 | 1 | 2000 | 2019 | ||||||||
|
B cell scaffold protein with ankyrin repeats 1 | 0.653 | 0.538 | 4.8E-12 |
|
disease | 0.700 | None | 0.955 | 1 | 2 | 2008 | 2019 | ||||||||
|
TNFAIP3 interacting protein 1 | 0.564 | 0.769 | 0.48 |
|
disease | 0.700 | None | 0.926 | 1 | 1 | 2009 | 2019 | ||||||||
|
PX domain containing serine/threonine kinase like | 0.821 | 0.231 | 1.1E-02 |
|
disease | 0.670 | None | 0.875 | 1 | 1 | 2008 | 2015 | ||||||||
|
Fc fragment of IgG receptor IIa | 0.480 | 0.769 | 2.0E-06 |
|
disease | 0.500 | None | 0.906 | 1 | 1 | 1995 | 2019 | ||||||||
|
PHD and ring finger domains 1 | 0.743 | 0.346 | 5.7E-02 |
|
disease | 0.470 | None | 0.875 | 1 | 1 | 2008 | 2012 | ||||||||
|
complement C2 | 0.617 | 0.692 | 1.3E-16 |
|
disease | 0.450 | strong | 1.000 | 1 | 2 | 1976 | 2015 | ||||||||
|
UHRF1 binding protein 1 | 0.769 | 0.269 | 4.5E-13 |
|
disease | 0.430 | None | 0.857 | 1 | 3 | 2009 | 2019 | ||||||||
|
C-type lectin domain containing 16A | 0.612 | 0.654 | 0.28 |
|
disease | 0.410 | None | 1.000 | 1 | 1 | 2009 | 2017 | ||||||||
|
RAS guanyl releasing protein 3 | 0.686 | 0.500 | 9.1E-03 |
|
disease | 0.410 | None | 1.000 | 1 | 1 | 2009 | 2017 | ||||||||
|
LYN proto-oncogene, Src family tyrosine kinase | 0.603 | 0.615 | 1.00 |
|
disease | 0.320 | None | 1.000 | 1 | 2 | 2001 | 2010 | ||||||||
|
lymphotoxin alpha | 0.434 | 0.885 | 0.20 |
|
disease | 0.200 | None | 0.786 | 1 | 1 | 1993 | 2017 | ||||||||
|
major histocompatibility complex, class I, A | 0.370 | 0.846 | 1.3E-03 |
|
disease | 0.200 | None | 1.000 | 1 | 1 | 1978 | 2014 | ||||||||
|
CD247 molecule | 0.539 | 0.731 | 1.7E-02 |
|
disease | 0.200 | None | 1.000 | 1 | 1 | 1998 | 2018 | ||||||||
|
major histocompatibility complex, class I, B | 0.379 | 0.885 | 3.9E-05 |
|
disease | 0.160 | None | 1.000 | 1 | 2 | 1991 | 2018 | ||||||||
|
CD80 molecule | 0.475 | 0.769 | 1.1E-02 |
|
disease | 0.150 | None | 1.000 | 1 | 1 | 2000 | 2017 | ||||||||
|
integrin subunit alpha X | 0.504 | 0.769 | 1.4E-15 |
|
disease | 0.150 | None | 1.000 | 1 | 2 | 2008 | 2019 | ||||||||
|
E74 like ETS transcription factor 1 | 0.691 | 0.462 | 1.1E-02 |
|
disease | 0.140 | None | 1.000 | 1 | 1 | 2002 | 2011 | ||||||||
|
major histocompatibility complex, class II, DM beta | 0.638 | 0.615 | 2.5E-03 |
|
disease | 0.130 | None | 0.750 | 1 | 1 | 1998 | 2014 | ||||||||
|
AT-rich interaction domain 5B | 0.638 | 0.500 | 1.00 |
|
disease | 0.130 | None | 1.000 | 1 | 1 | 2012 | 2016 | ||||||||
|
MHC class I polypeptide-related sequence B | 0.576 | 0.731 | 4.1E-05 |
|
disease | 0.130 | None | 1.000 | 1 | 1 | 2012 | 2017 | ||||||||
|
AF4/FMR2 family member 1 | 0.659 | 0.423 | 0.71 |
|
disease | 0.120 | None | 1.000 | 1 | 1 | 2012 | 2012 | ||||||||
|
inositol 1,4,5-trisphosphate receptor type 3 | 0.555 | 0.808 | 2.6E-22 |
|
disease | 0.120 | None | 1.000 | 1 | 1 | 2008 | 2010 | ||||||||
|
apolipoprotein M | 0.590 | 0.769 | 9.6E-04 |
|
disease | 0.120 | None | 1.000 | 1 | 1 | 2014 | 2019 | ||||||||
|
XK related 6 | 0.729 | 0.538 | 1.00 |
|
disease | 0.120 | None | 1.000 | 1 | 4 | 2008 | 2018 |